-transparent.png){kind=logo}
Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors. 1991
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Related Publications
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
April 1992,
Journal of immunotherapy : official journal of the Society for Biological Therapy,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
October 1991,
Cancer,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
June 1990,
Molecular biotherapy,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
November 1989,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
September 1991,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
January 1989,
European journal of cancer & clinical oncology,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
February 1991,
Presse medicale (Paris, France : 1983),
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
July 1990,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
October 1990,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J W Baars, and
J Wagstaff, and
E Boven, and
J B Vermorken, and
C J van Groeningen, and
R J Scheper, and
J C Fonk, and
H W Nijman, and
C R Franks, and
O Damsma
May 2001,
Journal of immunotherapy : official journal of the Society for Biological Therapy,
